RG-CD70

N/A

Report date: 2024/07/31 15:37:56

Base Information

Drug NameRG-CD70

Drug Alias NameRG-CD70

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy

Mechanisms of ActionNatural killer cell replacementsCD70 antigen modulators

TargetsCD70 antigen

Therapy Area/IndicationsLymphomaLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHangzhou Rongu Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Rongu Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsLymphomaLeukemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A